Patient Reported Outcome Measures in cancer care: a hybrid effectiveness-Implementation trial to optimise Symptom control and health service Experience (PROMISE)-protocol for a randomised controlled trial of electronic self-reporting of symptoms versus usual care during and following treatment in patients with cancer.

Abstract

Routine collection of patient-reported outcome measures (PROMs) has the potential to inform and improve cancer care. It is now feasible for patients to complete PROMs electronically (ePROMs) providing information about their current levels of symptoms, side effects of treatment and other concerns. PROM scores can be tracked over time allowing more timely identification of problems and more appropriate intervention. Studies have reported clear benefits in patient-clinician communication when PROMs are used and trials in the USA and France found patients randomised to complete regular ePROMs reported better health-related quality of life, had fewer unplanned hospital visits and, importantly, significantly better survival than those randomised to usual care. However, information about the effects on health outcomes and, particularly, the cost-effectiveness of incorporating this information into practice is limited.

Authors Webb, PM; Brown, A; Brown, B; Collins, LG; Crawford Williams, F; Doupain, K; Eastgate, M; Fennelly, V; Girgis, A; Hartel, G; Ladwa, R; Martin, K; Mason, R; McGuire, P; Miller, E; O'Brien, S; Packer, R; Pinkham, MB; Sabesan, S; Sanmugarajah, J; Slapp, G; Tapsall, D; White, J; Wishart, LR; Wyld, D; Chan, RJ
Journal BMJ Open
Pages e090836
Volume 14
Date 19/12/2024
Grant ID
Funding Body
URL http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1136/bmjopen-2024-090836